Agent for prophylaxis and treatment of glaucoma
AssigneesSenju Pharmaceutical Co., Ltd., Mitsubishi Pharma Corporation
InventorsMitsuyoshi Azuma, Yukuo Yoshida, Mitsunori Waki, Masayoshi Uehata
Life of this patent
Estimating the term…
Abstract
An agent for the prophylaxis and treatment of glaucoma, which contains a compound having a Rho kinase inhibitory activity, particularly an agent for the prophylaxis and treatment of glaucoma, which contains a compound of the formula (I) wherein each symbol is as defined in the specification, as the compound having a Rho kinase inhibitory activity, is provided. The agent for the prophylaxis and treatment of glaucoma of the present invention is a novel agent for the prophylaxis and treatment of glaucoma and has intraocular pressure lowering action, optic disc blood flow improving action and aqueous humor outflow promoting action.
Claims9
A method for treating asthenopia, which comprises administering an effective amount of a compound having a Rho kinase inhibitory activity to a patient having asthenopia.
A methods for treating pseudomyopia, which comprises administering an effective amount of a compound having a Rho kinase inhibitory activity to a patient having asthenopia.
Dependencies are inferred from the claim text.